GlassScriptPhysician profile
Christopher D Hobday
NPI 1154597888
$3,883.55
in general payments reported to CMS, 2019-2025
42 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $344 · 2021: $793 · 2022: $1,052 · 2023: $644 · 2024: $549 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $429.90 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $425.02 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $292.00 | 2019-2024 | Keytruda, Lynparza |
| Astellas Pharma US INC | $283.46 | 2022-2024 | Veozah, Cresemba |
| Myovant Sciences INC. | $230.93 | 2021-2022 | |
| Therapeuticsmd, INC. | $217.51 | 2019-2022 | |
| Pfizer INC. | $139.99 | 2019-2024 | |
| Daiichi Sankyo INC. | $131.97 | 2020-2023 | Injectafer |
| Pacira Pharmaceuticals Incorporated | $131.55 | 2020-2023 | Exparel, Iovera |
| Myriad Genetic Laboratories, INC. | $128.43 | 2021-2023 | Myrisk |
| Eisai INC. | $108.18 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $104.80 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $88.02 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $85.64 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $69.75 | 2019-2023 | Affirm Prone Biopsy System |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $68.92 | 2020-2023 | Slynd |
| Smith+Nephew, INC. | $68.61 | 2019-2023 | Stravix Pl |
| Ethicon US, LLC | $68.52 | 2021-2024 | Ethicon |
| Avion Pharmaceuticals | $68.05 | 2019-2020 | |
| Organon LLC | $66.25 | 2021-2023 | Nexplanon |
| Genmab U.S., INC. | $60.74 | 2022-2025 | Tivdak |
| Medtronic, INC. | $48.14 | 2022-2024 | Truclear |
| Amag Pharmaceuticals, INC. | $47.38 | 2019 | |
| Integra Lifesciences Corporation | $46.88 | 2024 | Codman Hakim, Duraseal Exact Spinal Sealant System, Codman Certas |
| Scynexis, INC. | $41.21 | 2021-2022 | |
| Coopersurgical, INC. | $39.88 | 2019-2022 | |
| Clovis Oncology, INC. | $39.53 | 2019 | |
| Baxter Healthcare | $38.54 | 2025 | Floseal |
| Aspira Women'S Health INC | $34.42 | 2019-2024 | Ova1 |
| Evofem Biosciences, INC. | $33.79 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $30.11 | 2019 | |
| Davol INC. | $25.07 | 2024 | Arista Ah Flexitip |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Allergan, INC. | $22.71 | 2019 | |
| Tesaro, INC. | $21.30 | 2019 | |
| Immunogen, INC. | $20.78 | 2023 | Elahere |
| Novartis Pharmaceuticals Corporation | $20.31 | 2023 | |
| Caris Mpi, INC. | $19.79 | 2025 | Mi Cancer Seek |
| Glaxosmithkline, LLC. | $18.32 | 2022 | |
| Millicent US INC | $15.28 | 2024 | Intrarosa, Femring |
| Meditrina | $14.58 | 2024 | |
| Medical Device Business Services, INC. | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hobday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.